(Q79678216)
Statements
Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology (English)
Timothy S Kern
Casey M Miller
Yunpeng Du
Ling Zheng
Susanne Mohr
M Kim
Jeffrey A Jamison
David P Bingaman
1 February 2007